Egberts TC - Search Results

1

Evaluation of post-authorization safety studies in the first cohort of EU Risk Management Plans at time of regulatory approval.

Giezen TJ, Mantel-Teeuwisse AK, Straus SM, Egberts TC, Blackburn S, Persson I, Leufkens HG. Giezen TJ, et al. Among authors: egberts tc. Drug Saf. 2009;32(12):1175-87. doi: 10.2165/11318980-000000000-00000. Drug Saf. 2009. PMID: 19916584

2

Can adverse drug reactions be detected earlier? A comparison of reports by patients and professionals.

Egberts TC, Smulders M, de Koning FH, Meyboom RH, Leufkens HG. Egberts TC, et al. BMJ. 1996 Aug 31;313(7056):530-1. doi: 10.1136/bmj.313.7056.530. BMJ. 1996. PMID: 8789980 Free PMC article. No abstract available.

3

Drug-related problems in hospitalised patients.

van den Bemt PM, Egberts TC, de Jong-van den Berg LT, Brouwers JR. van den Bemt PM, et al. Among authors: egberts tc. Drug Saf. 2000 Apr;22(4):321-33. doi: 10.2165/00002018-200022040-00005. Drug Saf. 2000. PMID: 10789826 Review.

4

Failure to continue lipid-lowering drug use following the withdrawal of cerivastatin.

Mantel-Teeuwisse AK, Klungel OH, Egberts TC, Verschuren WM, Porsius AJ, de Boer A. Mantel-Teeuwisse AK, et al. Among authors: egberts tc. Drug Saf. 2004;27(1):63-70. doi: 10.2165/00002018-200427010-00004. Drug Saf. 2004. PMID: 14720086

5

Risk of aplastic anemia in patients using antiepileptic drugs.

Handoko KB, Souverein PC, van Staa TP, Meyboom RH, Leufkens HG, Egberts TC, van den Bemt PM. Handoko KB, et al. Among authors: egberts tc. Epilepsia. 2006 Jul;47(7):1232-6. doi: 10.1111/j.1528-1167.2006.00596.x. Epilepsia. 2006. PMID: 16886988 Free article.

6

Signal detection: historical background.

Egberts TC. Egberts TC. Drug Saf. 2007;30(7):607-9. doi: 10.2165/00002018-200730070-00006. Drug Saf. 2007. PMID: 17604412

7

Platelet measurements versus discharge diagnoses for identification of patients with potential drug-induced thrombocytopenia: a cross-sectional study in the Netherlands.

ten Berg MJ, van Solinge WW, van den Bemt PM, Huisman A, Schobben AF, Egberts TC. ten Berg MJ, et al. Among authors: egberts tc. Drug Saf. 2009;32(1):69-76. doi: 10.2165/00002018-200932010-00006. Drug Saf. 2009. PMID: 19132806

8

Laboratory tests in the clinical risk management of potential drug-drug interactions: a cross-sectional study using drug-dispensing data from 100 Dutch community pharmacies.

Geerts AF, De Koning FH, De Smet PA, Van Solinge WW, Egberts TC. Geerts AF, et al. Among authors: egberts tc. Drug Saf. 2009;32(12):1189-97. doi: 10.2165/11316700-000000000-00000. Drug Saf. 2009. PMID: 19916585

9

Use of antidepressant drugs and risk of osteoporotic and non-osteoporotic fractures.

Verdel BM, Souverein PC, Egberts TC, van Staa TP, Leufkens HG, de Vries F. Verdel BM, et al. Among authors: egberts tc. Bone. 2010 Sep;47(3):604-9. doi: 10.1016/j.bone.2010.06.006. Epub 2010 Jun 18. Bone. 2010. PMID: 20601295

10

Comparison of potential risk factors for medication errors with and without patient harm.

Zaal RJ, van Doormaal JE, Lenderink AW, Mol PG, Kosterink JG, Egberts TC, Haaijer-Ruskamp FM, van den Bemt PM. Zaal RJ, et al. Among authors: egberts tc. Pharmacoepidemiol Drug Saf. 2010 Aug;19(8):825-33. doi: 10.1002/pds.1977. Pharmacoepidemiol Drug Saf. 2010. PMID: 20681001

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

250 results

Search Page

Filters